The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The efficacy and safety of Surufatinib monotherapy as a third-line treatment for advanced hepatocellular carcinoma: A single-arm, open-label, multi-center phase II study.
 
Fuxiang Zhou
No Relationships to Disclose
 
Lei Yang
No Relationships to Disclose
 
Jin Peng
No Relationships to Disclose
 
Hui Xu
No Relationships to Disclose
 
Han Wu
No Relationships to Disclose
 
You Wang
No Relationships to Disclose
 
Xin Long
No Relationships to Disclose
 
Qing Gao
No Relationships to Disclose
 
Xiangru Shi
No Relationships to Disclose
 
Jun Gong
No Relationships to Disclose
 
Jinmin Hu
No Relationships to Disclose